Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;2(4):608-620.
doi: 10.1016/j.gastha.2023.01.014. Epub 2023 Jan 21.

Noninvasive, MultiOmic, and Multicompartmental Biomarkers of Reflux Disease: A Systematic Review

Muhammad S Farooqi  1 , Sanjiti Podury  1 , George Crowley  1 , Urooj Javed  1 , Yiwei Li  2 , Mengling Liu  2 , Sophia Kwon  1 , Gabriele Grunig  3 , Abraham R Khan  4   5 , Fritz Francois  5 , Anna Nolan  1   3
Affiliations

Noninvasive, MultiOmic, and Multicompartmental Biomarkers of Reflux Disease: A Systematic Review

Muhammad S Farooqi et al. Gastro Hep Adv. 2023.

Abstract

Background and aims: Gastroesophageal reflux disease (GERD) is a prevalent gastrointestinal disorder that may complicate conditions such as obstructive airway disease. Our group has identified predictive biomarkers of GERD in particulate exposed first responders with obstructive airway disease. In addition, GERD diagnosis and treatment is costly and invasive. In light of these clinical concerns, we aimed to systematically review studies identifying noninvasive, multiOmic, and multicompartmental biomarkers of GERD.

Methods: A systematic review of PubMed and Embase was performed using keywords focusing on reflux disease and biomarkers and registered with PROSPERO. We included original human studies in English, articles focusing on noninvasive biomarkers of GERD published after December 31, 2009. GERD subtypes (non-erosive reflux disease and erosive esophagitis) and related conditions (Barrett's Esophagus [BE] and Esophageal Adenocarcinoma). Predictive measures were synthesized and risk of bias assessed (Newcastle-Ottawa Scale).

Results: Initial search identified n = 238 studies andn 13 articles remained after applying inclusion/exclusion criteria. Salivary pepsin was the most studied biomarker with significant sensitivity and specificity for GERD. Serum assessment showed elevated levels of Tumor Necrosis Factor-alpha in both GERD and Barrett's. Exhaled breath volatile sulfur compounds and acetic acid were associated with GERD. Oral Microbiome: Models with Lautropia, Streptococcus, and Bacteroidetes showed the greatest discrimination between BE and controls vs Lautropia; ROCAUC 0.94 (95% confidence interval; 0.85-1.00).

Conclusion: Prior studies identified significant multiOmic, multicompartmental noninvasive biomarker risks for GERD and BE. However, studies have a high risk of bias and the reliability and accuracy of the biomarkers identified are greatly limited, which further highlights the need to discover and validate clinically relevant noninvasive biomarkers of GERD.

Keywords: Barrett’s esophagus; Biomarkers; GERD; Reflux Disease; Systematic Review.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors disclose no conflicts.

Figures

Figure 1
Figure 1
Study design. Flow diagram as per PRISMA guidelines.,
Figure 2
Figure 2
Synthesis of biomarker outcomes. (A) Predictive values of pepsin. (B) Area under the receiver operator characteristic curve (ROCAUC) of biomarkers. (C) Odds ratio (OR) of biomarkers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717. - PMC - PubMed
    1. Savarino E., Bredenoord A.J., Fox M., et al. Advances in the physiological assessment and diagnosis of GERD. Nature Rev Gastroenterol & Hepatol. 2017;14:665. - PubMed
    1. Shaheen N.J., Hansen R.A., Morgan D.R., et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128–2138. - PubMed
    1. Richter J.E., Rubenstein J.H. Presentation and Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:267–276. - PMC - PubMed
    1. Francis D.O., Rymer J.A., Slaughter J.C., et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108:905–911. - PubMed